Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Polidocanol Versus Glucose For Sclerotherapy Treatment Of Telangiectasia Of The Lower Limbs: Protocol For A Randomized, Controlled Clinical Trial

NCT02657252 is registered in ClinicalTrials.gov with UPECLIN HC FM Botucatu Unesp as lead sponsor.

NCT NCT02657252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02657252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Polidocanol Versus Glucose For Sclerotherapy Treatment Of Telangiectasia Of The Lower Limbs: Protocol For A Randomized, Controlled Clinical Trial
Lead sponsor
UPECLIN HC FM Botucatu Unesp
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2015
Completion date
November 30, 2016
Enrollment
115 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

telangiectasis, varicose veins